Literature DB >> 17166727

Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration.

Maya G Purisai1, Alison L McCormack, Suzanne Cumine, Jie Li, Martha Z Isla, Donato A Di Monte.   

Abstract

Dopaminergic cells in the substantia nigra are highly vulnerable to the neurodegenerative process of Parkinson's disease. Therefore, mechanisms that enhance their susceptibility to injury bear important implications for disease pathogenesis. Repeated injections with the herbicide paraquat cause oxidative stress and a selective loss of dopaminergic neurons in mice. In this model, the first paraquat exposure, though not sufficient to induce any neurodegeneration, predisposes neurons to damage by subsequent insults. The purpose of this study was to elucidate the mechanisms underlying this "priming" event. We found that a single paraquat exposure was followed by an increase in the number of cells with immunohistochemical, morphological and biochemical characteristics of activated microglia, including induction of NADPH oxidase. If this microglial response was inhibited by the anti-inflammatory drug minocycline, subsequent exposures to the herbicide failed to cause oxidative stress and neurodegeneration. On the other hand, if microglial activation was induced by pre-treatment with lipopolysaccharide, a single paraquat exposure became capable of triggering a loss of dopaminergic neurons. Finally, mutant mice lacking functional NADPH oxidase were spared from neurodegeneration caused by repeated paraquat exposures. Data indicate that microglial activation and consequent induction of NADPH oxidase may act as risk factors for Parkinson's disease by increasing the vulnerability of dopaminergic cells to toxic injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17166727      PMCID: PMC2001246          DOI: 10.1016/j.nbd.2006.10.008

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  34 in total

1.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Du-Chu Wu; Peter Teismann; Kim Tieu; Miquel Vila; Vernice Jackson-Lewis; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

Review 2.  Epidemiology of neurodegeneration.

Authors:  Richard Mayeux
Journal:  Annu Rev Neurosci       Date:  2003-01-24       Impact factor: 12.449

Review 3.  The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?

Authors:  Donato A Di Monte
Journal:  Lancet Neurol       Date:  2003-09       Impact factor: 44.182

4.  Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons.

Authors:  Hui-Ming Gao; Bin Liu; Jau-Shyong Hong
Journal:  J Neurosci       Date:  2003-07-16       Impact factor: 6.167

Review 5.  Inflammation and neurodegeneration in Parkinson's disease.

Authors:  Patrick L McGeer; Edith G McGeer
Journal:  Parkinsonism Relat Disord       Date:  2004-05       Impact factor: 4.891

6.  Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.

Authors:  Mona Thiruchelvam; Alison McCormack; Eric K Richfield; Raymond B Baggs; A William Tank; Donato A Di Monte; Deborah A Cory-Slechta
Journal:  Eur J Neurosci       Date:  2003-08       Impact factor: 3.386

Review 7.  NADPH oxidase.

Authors:  Bernard M Babior
Journal:  Curr Opin Immunol       Date:  2004-02       Impact factor: 7.486

8.  Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity.

Authors:  Stephen K Van Den Eeden; Caroline M Tanner; Allan L Bernstein; Robin D Fross; Amethyst Leimpeter; Daniel A Bloch; Lorene M Nelson
Journal:  Am J Epidemiol       Date:  2003-06-01       Impact factor: 4.897

9.  Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.

Authors:  Honglei Chen; Shumin M Zhang; Miguel A Hernán; Michael A Schwarzschild; Walter C Willett; Graham A Colditz; Frank E Speizer; Alberto Ascherio
Journal:  Arch Neurol       Date:  2003-08

10.  Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease.

Authors:  Hui-Ming Gao; Bin Liu; Wanqin Zhang; Jau-Shyong Hong
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

View more
  87 in total

1.  Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3.

Authors:  Phillip M Rappold; Mei Cui; Adrianne S Chesser; Jacqueline Tibbett; Jonathan C Grima; Lihua Duan; Namita Sen; Jonathan A Javitch; Kim Tieu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 2.  Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors:  Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal:  Cell Mol Life Sci       Date:  2012-05-30       Impact factor: 9.261

3.  Quantitative determination of paraquat in meconium by sodium borohydride-nickel chloride chemical reduction and gas chromatography/mass spectrometry (GC/MS).

Authors:  Norberto C Posecion; Enrique M Ostrea; Dawn M Bielawski
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-11-12       Impact factor: 3.205

Review 4.  Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease.

Authors:  Derek A Drechsel; Manisha Patel
Journal:  Free Radic Biol Med       Date:  2008-03-04       Impact factor: 7.376

Review 5.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

6.  Dietary fat intake, pesticide use, and Parkinson's disease.

Authors:  Freya Kamel; Samuel M Goldman; David M Umbach; Honglei Chen; Gina Richardson; Marie Richards Barber; Cheryl Meng; Connie Marras; Monica Korell; Meike Kasten; Jane A Hoppin; Kathleen Comyns; Anabel Chade; Aaron Blair; Grace S Bhudhikanok; G Webster Ross; J William Langston; Dale P Sandler; Caroline M Tanner
Journal:  Parkinsonism Relat Disord       Date:  2013-10-01       Impact factor: 4.891

7.  Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions.

Authors:  Vinod Kumar; Brajesh Kumar Singh; Amit Kumar Chauhan; Deepali Singh; Devendra Kumar Patel; Chetna Singh
Journal:  Mol Neurobiol       Date:  2015-03-13       Impact factor: 5.590

Review 8.  Parkinson's disease and enhanced inflammatory response.

Authors:  Iva Stojkovska; Brandon M Wagner; Brad E Morrison
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

9.  Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression.

Authors:  P O Fernagut; C B Hutson; S M Fleming; N A Tetreaut; J Salcedo; E Masliah; M F Chesselet
Journal:  Synapse       Date:  2007-12       Impact factor: 2.562

Review 10.  Innate and adaptive immune responses in Parkinson's disease.

Authors:  Aubrey M Schonhoff; Gregory P Williams; Zachary D Wallen; David G Standaert; Ashley S Harms
Journal:  Prog Brain Res       Date:  2019-12-05       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.